Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome

MS Guaragna, F Casimiro, P Varela, L de S Feltran… - Pediatric …, 2025 - Springer
Predicting the risks of progression to chronic kidney disease (CKD) stage 5 in idiopathic
nephrotic syndrome (NS) and recurrence of the disease (rNS) following kidney …

[HTML][HTML] Emerging Role of SH3BP2 as Regulator of Immune and Nonimmune Cells in Nephrotic Syndrome

T Srivastava, M Sharma - Glomerular Diseases, 2024 - karger.com
Background: Minimal change disease (MCD) and focal segmental glomerulosclerosis
(FSGS) are major forms of nephrotic syndrome that remain difficult to treat. MCD and FSGS …

Quantifying the genetic contributions in unexplained kidney failure reveals APOL1-HLA interaction

O Sadeghi-Alavijeh, MMY Chan, K Tzoumkas… - medRxiv, 2024 - medrxiv.org
Background Unexplained kidney failure (uKF) affects 15% of individuals requiring kidney
replacement therapy. Absence of a diagnosis creates uncertainty around recurrence after …

Antinephrinantikörper als potenzieller Permeabilitätsfaktor bei proteinurischen Nierenerkrankungen

LA Völker - Die Nephrologie, 2024 - Springer
Hintergrund. Über die Rolle eines bislang unidentifizierten löslichen Permeabilitätsfaktors
bei Minimal Change Disease (dt. Erkrankung der glomerulären Minimalläsionen, MCD) und …

Genetic risk variants for childhood nephrotic syndrome and corticosteroid response

RK Cason, E Chambers, T Tu, M Chryst-Stangl… - Frontiers in …, 2023 - frontiersin.org
Introduction The etiology of most cases of nephrotic syndrome (NS) remains unknown,
therefore patients are phenotypically categorized based on response to corticosteroid …